New Medicines, Novel Insights: Accelerating development of cell and gene therapies

Cell and gene therapies offer extraordinary hope to patients with advanced cancers and genetic diseases but pose unprecedented challenges for sponsors. In this report, Parexel experts share insights that can bring these complex treatments to market faster and more efficiently.

Explore the report

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Podcast

Rare endpoints: Delivering on unmet patient needs

May 7, 2024

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Podcast

Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Jun 28, 2024

Webinar

Use of AI to develop health economic evidence for optimized patient access

Sep 6, 2023

Blog

CAR-T boxed warnings: regulatory precedents and opportunities

Feb 9, 2024

Video

Part 3: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future

May 15, 2024

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Related Insights

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Article

Near-term strategies for biotech drug developers facing shifting healthcare dynamics

Feb 14, 2024

Podcast

Rare endpoints: Delivering on unmet patient needs

May 7, 2024

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Show more